Preparation，physicochemical properties and pharmacokinetics in rats of CHMFL-KIT-110 solid dispersions
10.11665/j.issn.1000-5048.20200607
- VernacularTitle:CHMFL-KIT-110固体分散体制备、理化性质及大鼠体内药代动力学
- Author:
Yong WU
1
;
Dengjun CHEN
;
Xiao WANG
;
Hongzhang SUN
;
Meirong HUO
Author Information
1. 中国药科大学药学院药剂系
- Publication Type:Journal Article
- Keywords:
CHMFL-KIT-110;
amorphous solid dispersions;
Soluplus;
solubility;
bioavailability
- From:
Journal of China Pharmaceutical University
2020;51(6):688-695
- CountryChina
- Language:Chinese
-
Abstract:
Solid dispersions of the insoluble compound CHMFL-KIT-110 were prepared by solvent method with polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer (Soluplus),Poloxamer 407,PEG 6000,Copovidone (Kollidon VA64) as carriers and SLS,Tween 80,Cremophor RH40 as solubilizers. The optimal formulation was screened and obtained with dynamic solubilities and supersaturation performances as indexes. The final product was characterized by Fourier transform infrared (FT-IR),differential thermal analysis (DTA) and X-ray powder diffraction (XRPD). The stability and pharmacokinetic behavior in rats were also investigated. Results suggested that when the weight ratio of CHMFL-KIT-110/Soluplus/SLS was 1∶4∶0.5,dynamic solubility of the solid dispersions was significantly improved with no recrystallization. In the accelerated condition (40 °C,75% RH) for 30 days,CHMFL-KIT-110 in the solid dispersions was still amorphous with no crystal observed. The results of pharmacokinetics in rats showed that the cmax and AUC0→t of CHMFL-KIT-110 solid dispersions were 373.1 times and 358.7 times higher than those of free drugs,respectively. These results help to understand the formulation development and clinical practice of CHMFL-KIT-110.
